Cited by 1,294Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and TreatmentsCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 207 of the 208 references it cites were found in a registry or an index.

Translational biology of osteosarcoma

Kansara, Maya, Teng, Michele W., Smyth, Mark J., Thomas, David M.·2014·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

For the past 30 years, improvements in the survival of patients with osteosarcoma have been mostly incremental. Despite evidence of genomic instability and a high frequency of chromothripsis and kataegis, osteosarcomas carry few recurrent targetable mutations, and trials of targeted agents have been generally disappointing. Bone has a highly specialized immune environment and many immune signalling pathways are important in bone homeostasis. The success of the innate immune stimulant mifamurtide in the adjuvant treatment of non-metastatic osteosarcoma suggests that newer immune-based treatments, such as immune checkpoint inhibitors, may substantially improve disease outcome.

Integrity signals

Registry

Crossref · 10.1038/nrc3838

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Self-citation
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
WHO Classification of Tumours of Soft Tissue and Bone: WHO Classification of Tumours, vol. 5
Fletcher, C. D. �., Bridge, J., Hogendoorn, P. C. W., & Mertens, F. (2013) · Cited by 3,072
WHO classification of tumours of soft tissue and bone
Fletcher, C. D. �. (2013) · Cited by 2,874
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478

Flagged first, then by citations

Show all 208 references

1 of the 208 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Lussier, D. M. et al. 28th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC) 162 (Society for Immunotherapy of Cancer, 2013).

Sorted by citations

Items 101–200 of 1,000

METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma
Li, H., Huang, G., Tu, J., Lv, D., Jin, Q., Chen, J.-K., Zou, Y., Lee, D., Shen, J., & Xie, X. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104142 · Cited by 80
Black Mn-containing layered double hydroxide coated magnesium alloy for osteosarcoma therapy, bacteria killing, and bone regeneration
Zhang, D., Cheng, S., Tan, J., Xie, J., Zhang, Y., Chen, S., Du, H., Qian, S., Qiao, Y., Peng, F., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.032 · Cited by 79
PD-1 and PD-L1 expression in bone and soft tissue sarcomas
Torabi, A., Amaya, C. N., Wians, F. H., & Bryan, B. A. (2017) · Pathology · doi:10.1016/j.pathol.2017.05.003 · Cited by 78
Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy
Xi, Y., Jiang, T., Yu, Y., Yu, J., Xue, M., Xu, N., Wen, J., Wang, W., He, H., Shen, Y., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s211981 · Cited by 78
A multifunctional antibacterial coating on bone implants for osteosarcoma therapy and enhanced osteointegration
Zhang, G., Wu, Z., Yang, Y., Shi, J., Lv, J., Fang, Y., Shen, Z. Z., Lv, Z., Li, P., Yao, X., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.131155 · Cited by 77
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
Wang, Z., Wang, Z., Li, B., Wang, S., Chen, T., & Ye, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01114 · Cited by 77
Exosomal MiRNAs in Pediatric Cancers
Galardi, A., Colletti, M., Paolo, V. D., Vitullo, P., Antonetti, L., Russo, I., & Giannatale, A. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184600 · Cited by 77
Cold Plasma-Treated Ringer’s Saline: A Weapon to Target Osteosarcoma
Mateu‐Sanz, M., Tornín, J., Brulin, B., Khlyustova, A. V., Ginebra, M., Layrolle, P., & Canal, C. (2020) · Cancers · doi:10.3390/cancers12010227 · Cited by 76
Monofunctional Platinum(II) Anticancer Agents
Jin, S., Guo, Y., Guo, Z., & Wang, X. (2021) · Pharmaceuticals · doi:10.3390/ph14020133 · Cited by 78
Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
Weekes, D. B., Kashima, T. G., Zandueta, C., Perurena, N., Thomas, D. P., Sunters, A., Vuillier, C., Bozec, A., El‐Emir, E., Milétich, I., et al. (2015) · Oncogene · doi:10.1038/onc.2015.344 · Cited by 75
Self-citation
Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation
Han, Y., Feng, H., Sun, J., Liang, X., Wang, Z., Xing, W., Dai, Q., Yang, Y., Han, A., Wei, Z., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124590 · Cited by 74
Retracted
miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells
Luo, Y., Liu, W. Y., Tang, P., Jiang, D., Gu, C., Huang, Y., Gong, F., Rong, Y., Qian, D., Chen, J., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1491-6 · Cited by 73
Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies
Yuan, Y., Diao, S., Ni, X., Zhang, D., Yi, W., Jian, C., Hu, X., Li, D., Yu, A., Zhou, W. J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01249-4 · Cited by 73
SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma
Wu, W., Zhang, Z., Jing, D., Huang, X., Ren, D., Shao, Z., & Zhang, Z. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04980-w · Cited by 73
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
Wang, Z., Li, B., Ren, Y., & Ye, Z. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00353 · Cited by 73
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases
Koelsche, C., Schrimpf, D., Tharun, L., Roth, E. K., Sturm, D., Jones, D., Renker, E.-K., Sill, M., Baude, A., Sahm, F., et al. (2017) · Clinical Sarcoma Research · doi:10.1186/s13569-017-0075-5 · Cited by 75
Integrated Analysis of Transcriptome-Wide m 6 A Methylome of Osteosarcoma Stem Cells Enriched by Chemotherapy
Wang, Y., Zeng, L., Liang, C., Zan, R., Ji, W., Zhang, Z., Wei, Y., Tu, S., & Dong, Y. (2019) · Epigenomics · doi:10.2217/epi-2019-0262 · Cited by 73
Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming
Mazumdar, A., Urdinez, J., Boro, A., Migliavacca, J., Arlt, M. J. E., Muff, R., Fuchs, B., Snedeker, J. G., & Gvozdenovic, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155451 · Cited by 71
Intraoperative fluorescence imaging in thoracic surgery
Newton, A. D., Predina, J. D., Nie, S., Low, P. S., & Singhal, S. K. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25149 · Cited by 71
Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle
Fang, Z., Sun, Y., Xiao, H. P., Li, P., Liu, M., Ding, F., Kan, W., & Miao, R. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.132 · Cited by 71
Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription
Chen, F., Mo, J., & Zhang, L. (2016) · Tumor Biology · doi:10.1007/s13277-016-5256-y · Cited by 70
miR-210-5p promotes epithelial–mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells
Liu, W., Jiang, D., Gong, F., Huang, Y., Luo, Y., Rong, Y., Wang, J., Ge, X., Ji, C., Fan, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2270-1 · Cited by 70
Role of autophagy in osteosarcoma
Camuzard, O., Santucci‐Darmanin, S., Carle, G. F., & Pierrefite‐Carle, V. (2019) · Journal of bone oncology · doi:10.1016/j.jbo.2019.100235 · Cited by 70
Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours
Inagaki, Y., Hookway, E. S., Williams, K., Hassan, A. B., Oppermann, U. C. T., Tanaka, Y., Soilleux, E. J., & Athanasou, N. A. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0053-3 · Cited by 72
Single-cell RNA sequencing in orthopedic research
Wang, T., Wang, L., Zhang, L., Long, Y., Zhang, Y., & Hou, Z. (2023) · Bone Research · doi:10.1038/s41413-023-00245-0 · Cited by 68
Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway
Wang, C., Zhou, X., Li, W., Li, M., Tu, T., Ba, X., Wu, Y., Huang, Z. D., Fan, G., Zhou, G., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.011 · Cited by 69
The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy
Wang, H., Zhou, X., Li, C., Yan, S., Feng, C., He, J., Li, Z., & Tu, C. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01365-6 · Cited by 68
Managing sarcoma: where have we come from and where are we going?
Bleloch, J., Ballim, R. D., Kimani, S., Parkes, J., Panieri, E., Willmer, T., & Prince, S. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017728927 · Cited by 69
Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
He, C., Liu, C., Wang, L., Sun, Y., Jiang, Y., & Hao, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1347-1 · Cited by 66
Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study
Chen, B., Zeng, Y., Liu, B., Lu, G., Xiang, Z., Chen, J., Yan, Y., Zuo, Z., Lin, Y., & Ma, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.672024 · Cited by 68
MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN
Chen, J., Yan, D., Wu, W., Zhu, J., Ye, W., & Shu, Q. (2016) · Oncology Reports · doi:10.3892/or.2016.4719 · Cited by 65
Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis
Homayoonfal, M., Asemi, Z., & Yousefi, B. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00320-0 · Cited by 64
Detection of circulating tumor DNA in patients with osteosarcoma
Barris, D. M., Weiner, S. B., Dubin, R. A., Fremed, M., Zhang, X., Piperdi, S., Zhang, W., Maqbool, S., Gill, J., Roth, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24268 · Cited by 63
Exosomal Transfer of LCP1 Promotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2/STAT3 Signaling Pathway
Ge, X., Liu, W., Zhao, W., Feng, S., Duan, A., Ji, C., Shen, K., Liu, W., Zhou, J., Jiang, D., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.025 · Cited by 63
Bone responses in health and infectious diseases: A focus on osteoblasts
Terrier, C. S.-P., & Gasque, P. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.07.007 · Cited by 63
Long noncoding RNA ATB promotes osteosarcoma cell proliferation, migration and invasion by suppressing miR-200s.
Han, F., Wang, C., Wang, Y., & Zhang, L. (2017) · PubMed Central · Cited by 63
Targeting of cancer stem cells by differentiation therapy
Arima, Y., Nobusue, H., & Saya, H. (2020) · Cancer Science · doi:10.1111/cas.14504 · Cited by 67
Wnt/β‐Catenin Signaling Activates Expression of the Bone‐Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types
Vega, O. A., Lucero, C. M. J., Araya, H., Jerez, S., Tapia, J. C., Antonelli, M., Salazar‐Onfray, F., Heras, F. L., Thaler, R., Riester, S. M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26011 · Cited by 62
Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
Li, P., Tu, M., Ho, P. Y., Jilek, J. L., Duan, Z., Zhang, Q.-Y., Yu, A., & Yu, A. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078741 · Cited by 62
Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Zhang, X., Wei, C., Liang, H., & Han, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.587554 · Cited by 61
3D Printed Bioceramic Scaffolds as a Universal Therapeutic Platform for Synergistic Therapy of Osteosarcoma
Dang, W., Yi, K., Ju, E., Jin, Y., Xu, Y., Wang, H., Chen, W.-C., Wang, K., Wang, Y., Tao, Y., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00553 · Cited by 61
The role of pharmacogenetics in the treatment of osteosarcoma
Vos, H. I., Coenen, M. J. H., Guchelaar, H., & Loo, D. M. W. M. T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.022 · Cited by 61
Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges
Hsu, J. Y., Seligson, N. D., Hays, J. L., Miles, W. O., & Chen, J. L. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00211 · Cited by 60
NIR Responsive Doxorubicin‐Loaded Hollow Copper Ferrite @ Polydopamine for Synergistic Chemodynamic/Photothermal/Chemo‐Therapy
Chu, X., Zhang, L., Li, Y., He, Y. H., Zhang, Y. X., & Du, C. (2022) · Small · doi:10.1002/smll.202205414 · Cited by 60
Autophagy regulation by microRNAs : Novel insights into osteosarcoma therapy
Jamali, Z., Taheri‐Anganeh, M., Shabaninejad, Z., Keshavarzi, A., Taghizadeh, H., Razavi, Z. S., Mottaghi, R., Abolhassan, M., Movahedpour, A., & Mirzaei, H. (2020) · IUBMB Life · doi:10.1002/iub.2277 · Cited by 60
RETRACTED ARTICLE: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
Liao, D., Zhong, L., Yin, J., Zeng, C., Wang, X., Huang, X., Chen, J., Zhang, H., Zhang, R., Guan, X., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0522-z · Cited by 60
Retracted
Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase.
HIRSCH, R. J., Lupo, M. P., Cohen, J. L., & Duffy, D. M. (2007) · PubMed · Cited by 60
Improving Bioavailability of Hydrophobic Prodrugs through Supramolecular Nanocarriers Based on Recombinant Proteins for Osteosarcoma Treatment
Wang, S., Li, B., Zhang, H., Chen, J., Sun, X., Xu, J. H., Ren, T., Zhang, Y., Ma, C., Guo, W., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101938 · Cited by 59
Genomics and the Immune Landscape of Osteosarcoma
Wu, C.-C., & Livingston, J. A. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-43085-6_2 · Cited by 58
PROTAC induced-BET protein degradation exhibits potent anti-osteosarcoma activity by triggering apoptosis
Shi, C., Zhang, H., Wang, P., Wang, K., Xu, D., Wang, H., Yin, L., Zhang, S., & Zhang, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2022-2 · Cited by 58
The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
Zeng, M., Zhou, J., Wen, L., Zhu, Y., Luo, Y., & Wang, W. (2021) · BMC Cancer · doi:10.1186/s12885-021-07880-y · Cited by 58
Multifunctional 3D-printed scaffolds eradiate orthotopic osteosarcoma and promote osteogenesis via microwave thermo-chemotherapy combined with immunotherapy
Ma, L., Zhou, J., Wu, Q., Luo, G., Zhao, M., Zhong, G., Zheng, Y., Meng, X., Cheng, S., & Zhang, Y. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122236 · Cited by 58
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells
Li, Y., Xian, M., Yang, B., Ying, M., & He, Q. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.025 · Cited by 59
Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism
Kim, H., Yoo, S., Zhou, R., Xu, A., Bernitz, J. M., Yuan, Y., Gomes, A., Daniel, M. G., Su, J., Demicco, E. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814044115 · Cited by 59
RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
Feng, W., Dean, D. C., Hornicek, F. J., Spentzos, D., Hoffman, R. M., Shi, H., & Duan, Z. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920922055 · Cited by 57
Retracted
CircRNA–miRNA networks in regulating bone disease
Huang, W., Wu, Y., Qiao, M., Xie, Z., Cen, X. B., Huang, X., & Zhao, Z. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30625 · Cited by 56
Novel Immunotherapies for Osteosarcoma
Lu, Y., Zhang, J., Chen, Y., Kang, Y., Liao, Z., He, Y., & Zhang, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.830546 · Cited by 58
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Martínez-Vélez, N., Xipell, E., Vera, B., de la Rocha, A. A., Zalacaín, M., Marrodán, L., González-Huarriz, M., Toledo, G., Cascalló, M., Alemany, R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1899 · Cited by 57
Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration
Fu, Y., Bao, Q., Liu, Z., He, G., Wen, J., Liu, Q., Xu, Y., Jin, Z., & Zhang, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.633607 · Cited by 55
Exploring the diverse applications of Carbohydrate macromolecules in food, pharmaceutical, and environmental technologies
Ramaprabha, K., Kumar, S. V., Saravanan, P., Rajeshkannan, R., Rajasimman, M., Kamyab, H., & Vasseghian, Y. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117521 · Cited by 55
Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
Wagner, L. M., & Adams, V. R. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s124008 · Cited by 57
miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9
Wang, W., Qi, Q., Zhao, P., Li, C.-Y., Yin, X.-Y., & Yan, R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.124 · Cited by 55
Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma
Cheng, L., Pandya, P. H., Liu, E., Chandra, P., Wang, L., Murray, M. E., Carter, J., Ferguson, M. J., Saadatzadeh, M. R., Bijangi‐Vishehsaraei, K., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0456-5 · Cited by 55
Advances in differentiation therapy for osteosarcoma
Chen, Y., Cao, J., Zhang, N., Yang, B., He, Q., Shao, X., & Ying, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.08.010 · Cited by 54
1064 nm activatable semiconducting polymer-based nanoplatform for NIR-II fluorescence/NIR-II photoacoustic imaging guided photothermal therapy of orthotopic osteosarcoma
Li, D., Zhang, C., Tai, X., Xu, D., Xu, J., Sun, P., Fan, Q., Cheng, Z., & Zhang, Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.136836 · Cited by 54
Progress and Opportunities for Immune Therapeutics in Osteosarcoma
Lettieri, C. K., Appel, N., Labban, N., Lussier, D. M., Blattman, J. N., & Hingorani, P. (2016) · Immunotherapy · doi:10.2217/imt-2016-0048 · Cited by 54
Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients
Li, X., Chen, Y., Liu, X., Zhang, J. C., Xu, H., Teng, G., & Yu, D. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.01.006 · Cited by 56
mi RNA profiling identifies deregulated mi RNA s associated with osteosarcoma development and time to metastasis in two large cohorts
Andersen, G. B., Knudsen, A., Hager, H., Hansen, L. L., & Tost, J. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12154 · Cited by 54
Polyphyllin VI induces apoptosis and autophagy in human osteosarcoma cells by modulation of ROS/JNK activation
Yuan, Y., Jiang, N., Li, Z., Song, Z., Yang, Z., Xue, W., Zhang, X., & Du, Y. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s194961 · Cited by 54
Osteosarcoma and Metastasis Associated Bone Degradation—A Tale of Osteoclast and Malignant Cell Cooperativity
Nørregaard, K. S., Jürgensen, H. J., Gårdsvoll, H., Engelholm, L. H., Behrendt, N., & Søe, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136865 · Cited by 56
Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo
Chang, J., Li, Y., Wang, X., Hu, S., Wang, H., Shi, Q. W., Wang, Y., & Yang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-07194-9 · Cited by 53
lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell�proliferation, migration and invasion in osteosarcoma
Deng, R., Zhang, J., & Chen, J.-T. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4039 · Cited by 53
The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases
Navet, B., Ando, K., Vargas-Franco, J. W., Brion, R., Amiaud, J., Mori, K., Yagita, H., Mueller, C. G., Verrecchia, F., Dumars, C., et al. (2018) · Cancers · doi:10.3390/cancers10110398 · Cited by 52
Ezrin Inhibition Up-regulates Stress Response Gene Expression
Çelik, H., Bulut, G., Han, J. J., Graham, G. T., Minas, T. Z., Conn, E. J., Hong, S.-H., Pauly, G. T., Hayran, M., Li, X., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.718189 · Cited by 53
Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment
Fioramonti, M., Fausti, V., Pantano, F., Iuliani, M., Ribelli, G., Lotti, F., Pignochino, Y., Grignani, G., Santini, D., Tonini, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22469-5 · Cited by 52
LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses
Vimalraj, S., Subramanian, R., & Dhanasekaran, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.742789 · Cited by 51
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Fan, Q., Zuo, J., Tian, H., Huang, C., Nice, E. C., Shi, Z., & Kong, Q. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02372-8 · Cited by 51
MXene‐Integrated Composites for Biomedical Applications: Synthesis, Cancer Diagnosis, and Emerging Frontiers
Saxena, A., Tyagi, A., Vats, S., Gupta, I., Gupta, A., Kaur, R., Tiwary, S. K., Elzatahry, A. A. F., Singh, M., & Karim, A. (2025) · Small Science · doi:10.1002/smsc.202400492 · Cited by 52
Deciphering signaling networks in osteosarcoma pathobiology
Adamopoulos, C., Gargalionis, A. N., Basdra, E. K., & Papavassiliou, A. G. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216648806 · Cited by 51
miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675.
He, P., Zhang, Z., Huang, G., Wang, H., Xu, D., Liao, W., & Kang, Y. (2016) · PubMed Central · Cited by 51
Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23
Kansara, M., Thomson, K., Pang, P., Dutour, A., Mirabello, L. J., Acher, F., Pin, J., Demicco, E. G., Yan, J., Teng, M. W. L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0154 · Cited by 52
Self-citation
Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression
Díaz, E. C. G., Sinha, S., Avedian, R. S., & Yang, F. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.08.020 · Cited by 52
FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity
Wu, W., Jing, D., Meng, Z., Hu, B., Zhong, B., Deng, X., Jin, X., & Shao, Z. (2020) · Theranostics · doi:10.7150/thno.41279 · Cited by 50
Pyroptosis, a New Breakthrough in Cancer Treatment
Wu, D., Wei, C., Li, Y., Yang, X., & Zhou, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698811 · Cited by 52
The Osteoclast Traces the Route to Bone Tumors and Metastases
Russo, S., di Carlo, F. S., & Gianfrancesco, F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.886305 · Cited by 50
Advances in cell membrane-coated nanoparticles and their applications for bone therapy
Chen, Y., Zhu, M., Huang, B., Jiang, Y., & Su, J. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213232 · Cited by 49
LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis
Pan, X., Guo, J., Liu, C., Pan, Z., Yang, Z., Yao, X., & Yuan, J. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00304-6 · Cited by 49
The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models
Zhu, Y., Zhou, X., Zhu, L., Yao, C., Fang, J., Zhou, F., Deng, X., & Zhang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10389 · Cited by 48
Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
Takagi, S., Sasaki, Y., Koike, S., Takemoto, A., Seto, Y., Haraguchi, M., Ukaji, T., Kawaguchi, T., Sugawara, M., Saito, M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01956-6 · Cited by 48
One-Dimensional Ferroelectric Nanoarrays with Wireless Switchable Static and Dynamic Electrical Stimulation for Selective Regulating Osteogenesis and Antiosteosarcoma
Xiao, C., Fan, L., Zhou, S., Kang, X., Guan, P., Fu, R., Li, C., Ren, J. M., Wang, Z., Yu, P., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c07900 · Cited by 49
NGR‐Modified CAF‐Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma
Du, J., Meng, X., Yang, M., Chen, G., Li, J., Zhu, Z., Wu, X., Hu, W., Tian, M., Li, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202410918 · Cited by 48
CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma
Xu, L., Li, L., Li, Y., Zhao, J., Fan, S., & Wang, L. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s104513 · Cited by 48
A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma
Liu, F., Xing, L., Zhang, X., & Zhang, X. (2019) · Genes · doi:10.3390/genes10060414 · Cited by 48
Genetically Engineered Pigs to Study Cancer
Kalla, D., Kind, A., & Schnieke, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020488 · Cited by 51
Organoid culture system for patient-derived lung metastatic osteosarcoma
He, A., Huang, Y., Cheng, W., Zhang, D., He, W., Bai, Y., Gu, C., Ma, Z., He, Z., Si, G., et al. (2020) · Medical Oncology · doi:10.1007/s12032-020-01429-y · Cited by 48
FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53
Li, H., Han, X., Yang, S., Wang, Y., Dong, Y., & Tang, T. (2021) · Oncogene · doi:10.1038/s41388-021-01742-4 · Cited by 48
miR-485-3p regulated by MALAT1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling
Wang, Q., Liu, M., Bu, J., Deng, J., Jiang, B., Jiang, L., & He, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118925 · Cited by 47
Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma
Chim, L. K., Williams, I. L., Bashor, C. J., & Mikos, A. G. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122076 · Cited by 47
Exosomes in Bone Sarcomas: Key Players in Metastasis
Chicón‐Bosch, M., & Tirado, Ò. M. (2020) · Cells · doi:10.3390/cells9010241 · Cited by 50
Magnesium alloys in tumor treatment: Current research status, challenges and future prospects
Hsu, Y., Lu, Y., Wang, S., Zheng, Y., Xia, D., & Liu, Y. (2023) · Journal of Magnesium and Alloys · doi:10.1016/j.jma.2023.08.008 · Cited by 47

Authors: Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M.
Affiliations: The University of Melbourne (AU)
The University of Queensland (AU)
Garvan Institute of Medical Research (AU)
Corresponding author: Thomas, David M.
ORCID: Kansara, Maya
Teng, Michele W.
Smyth, Mark J.
Thomas, David M.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2014-10-16
Volume: 14
Issue: 11
Pages: 722-735
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc3838
OpenAlex: W1980088710
Cited by: 1,294
References: 208
Citations by year: 2026: 66 · 2025: 130 · 2024: 134 · 2023: 155 · 2022: 161 · 2021: 173 · 2020: 152 · 2019: 86 · 2018: 66 · 2017: 74 · 2016: 65 · 2015: 29 · 2014: 2
FWCI: 9.69
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: National Health and Medical Research Council
National Medical Research Council
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: osteosarcoma, bone biology, bone homeostasis, germline predisposition, cancer genomics, chromothripsis, kataegis, genomic instability, targeted therapy, mifamurtide, immune checkpoint inhibitors, adjuvant therapy, metastatic osteosarcoma, translational research
MeSH terms: Animals, Antineoplastic Agents, Bone Development, Humans, Osteosarcoma, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Translational biology of osteosarcoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks